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Breast cancer hijacks dendritic cells
On  page  1037, Aspord et al. find that im-
mune  cells are swayed to the dark side by 
cancerous forces. Instead of priming a killing 
response, dendritic cells (DCs) that infiltrate 
breast tumors actually help the tumor grow.
The group previously found that human 
breast tumors often include a large number of 
mature dendritic cells that form clusters with 
CD4+ T cells. This association suggested that 
immunity was at work in the tumor, but it also 
hinted at an oddity: mature DCs are normally 
found in lymph nodes, not the affected tissue.
To figure out what these DCs were doing in the tumors, Aspord and 
colleagues studied humanized mice that were grafted with human breast 
cancer cell lines. In these mice, the DCs recruited CD4+  T cells to the tu-
mors but did not prime an antitumor immune response. Instead, the DCs 
instigated the T cells to secrete IL-13 and thereby promote tumor growth.
IL-13 helped tumors by activating a signaling pathway that has been 
implicated in metastasis. But why the DCs initiated this tumor-friendly 
response is still unclear.
The findings might help explain why DC-based vaccine therapies 
sometimes fail in clinical trials. The team now plans to test IL-13 an-
tagonists in breast cancer patients in combination with candidate DC 
vaccines. The hope is that the antagonists will prevent the vaccine-
induced antitumor immunity from being subverted into a cancer-
promoting response. 
Lipid tails dictate NKT cell response
Short lipid chains tweak the responses of natural killer T (NKT) cells by 
weakening the binding between the T cell receptor (TCR) and the lipid-
presenting protein, report McCarthy et al. on page 1131.
Lipid antigens are presented to NKT cells by the surface glycoprotein 
CD1d. These fatty antigens are composed of a hydrophilic head that is 
exposed to the TCR on the NKT cells, and two hydrophobic tails. Each tail—
an acyl chain and a fatty acid chain—is tucked away inside separate 
grooves within the CD1d molecule.
Previous studies showed that shorter lipid chains destabilize the 
binding of the lipid antigen to CD1d. Whereas some of these short ligands 
simply reduce the ability of CD1d to activate an NKT cell, others switch the 
NKT response from interferonγ to interleukin-4 production.
McCarthy et al. now find that shortening either the acyl or the fatty acid 
chain destabilizes the CD1d-lipid complex. The shorter fatty acid chain, 
however, also reduces the binding affinity between the CD1d-lipid complex 
and the TCR. The NKT cells are therefore unable 
to induce clustering of CD1d-lipid complexes 
and fail to form a productive synapse with the 
antigen presenting cell. The authors propose 
that the stumpy fatty acid chain doesn’t 
completely fill its CD1d groove, which 
consequently collapses. This new conformation 
might lead to a less stable interaction between 
the complex and the TCR. 
Breast tumor size increases 
when DCs and T cells team 
up (red).
B cells blunt 
neonatal immunity
Infants are easy targets for viruses and bacteria, 
as their immune responses lack the punch to 
ward off pathogens. Zhang et al. (page 1107) 
now find that young immune systems are well 
developed but are sabotaged by a group of 
childish B cells.
In adults, microbes trigger defense responses 
by activating Toll-Like Receptors (TLRs) on den-
dritic cells (DCs). The DCs then ramp up defense 
by secreting Interferons α and β (IFN α/β), 
which are toxic to pathogens, and pro-inflam-
matory TNF and interleukin-12 (IL-12), which 
reinforce inflammation by activating T cells.
In newborns, however, TNF and IL-12 are 
only weakly produced during inflammation, 
even though neonatal DCs produce these cyto-
kines when stimulated in vitro. To identify the 
in vivo roadblock, Zhang et al. focused on the 
anti-inflammatory cytokine IL-10, as it is a 
known inhibitor of TNF and IL-12 production. In 
an earlier study, the group found that IL-10 is 
produced by a subset of B cells that are more 
abundant in newborns than in adults.
The team now shows that these B cells 
overwhelm inflammatory responses in newborn 
mice. Pathogens triggered TLRs on both B cells 
and DCs. The B cells responded by producing 
IL-10, while the DCs made IFNα/β. But instead of 
stoking inflammation, the IFNα/β enhanced B 
cell IL-10 production, which then blocked DC 
secretion of TNF/IL-12. This regulatory loop 
sabotaged anti-microbial immunity in newborns, 
but it also had a positive effect: it allowed 
young mice to avoid overenthusiastic and 
potentially lethal inflammatory responses. The 
team speculates that this mechanism might 
also prevent human infants from succumbing to 
inflammation. Adults do not get the same 
benefit, as their IL-10-secreting B cells are 
vastly out-numbered by inflammatory DCs. 
Lipid antigens have to be long enough for cytotoxic granules (green) to move from the 
rear of NKT cells to the immunological synapse (left to right).